GRIK5 antibody (Extracellular)
Quick Overview for GRIK5 antibody (Extracellular) (ABIN7043241)
Target
See all GRIK5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 430-442, Extracellular
-
Purpose
- A Rabbit Polyclonal Antibody to Kainate Receptor GluK5
-
Specificity
- Extracellular, N-terminus
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Human,mouse - identical
-
Characteristics
- Anti-GRIK5 (GluK5) (extracellular) Antibody is directed against an epitope of the rat kainate receptor GluK5. Anti-GRIK5 (GluK5) (extracellular) Antibody (ABIN7043241, ABIN7044382 and ABIN7044383) can be used in western blot, immunocytochemistry, and immunohistochemistry applications. The antibody recognizes an extracellular epitope and is thus ideal for detecting the receptor in living cells. It has been designed to recognize GluK5 from rat, human, and mouse samples.
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogen
-
Immunogen: Synthetic peptide
Immunogen Sequence: (C)RRPNFQALSGNER,corresponding to amino acid residues 430-442 of rat kainate receptor GluK5
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Antigen preadsorption control: 1 μg peptide per 1 μg antibody
Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:300
Application Dilutions Western blot wb: 1:400
-
Comment
-
Negative Control: (ABIN7235669)
Blocking Peptide: (ABIN7235669)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
-
-
- GRIK5 (Glutamate Receptor, Ionotropic, Kainate 5 (GRIK5))
-
Alternative Name
- GRIK5
-
Background
-
Glutamate receptor ionotropic kainate 5, Glutamate receptor KA-2, KA2,There are three glutamate receptor superfamilies defined by the specific agonist binding to them - NMDA, AMPA and kainate.Several types of kainate receptors have been cloned and classified. Two of these have a high affinity to kainate (GLUK1 and GLUK2), while GLUK5, as well as other members of the family, have a lower affinity1. GLUK5, GLUK6 and GLUK7 have a 75-80 % identical amino acid sequence making them a separate subfamily from the other kainate receptors.The GLUK5 receptor, similar to its subfamily members, is a ligand-gated ion channel. It has an extracellular N-terminus comprised of eight glycosylation consensus sites, four transmembrane domains arranged in a three-plus-one pattern with a large intracellular domain between units three and four and a C-terminus2. GLUK5 is expressed in DRG neuron cell bodies where currents in these cells are preferentially induced by kainate and not AMPA3 and also in trigeminal neurons where kainate receptor antagonists are effective in a dural plasma protein extravasation model of migraine in rats4.Little is known about the role of GLUK5 in pathologies. A study examining the role of the receptor in brain pathology using GLUK5 antagonists on hippocampal cells slices, found that blocking of the kainate receptor prevents the development of epileptic activity evoked by muscarinic antagonist. The administration of GLUK5 antagonists to conscious mice in the same study showed that the antagonist prevents limbic seizures induced by hippocampal pilocarpine perfusion without evident side effects. These findings suggest that GLUK5 antagonists may be effective in the treatment of epilepsy and further research in this field is required5.
Alternative names: GRIK5 (GluK5), Glutamate receptor ionotropic kainate 5, Glutamate receptor KA-2, KA2 -
Gene ID
- 24407
-
NCBI Accession
- NM_001301030
-
UniProt
- Q63273
-
Pathways
- Carbohydrate Homeostasis, Synaptic Membrane, Maintenance of Protein Location, Synaptic Vesicle Exocytosis
Target
-